Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.
NCT07206017 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-10-03
Summary
Exploring the effect of supplementation with daily addition of prebiotic dried chicory root (WholeFiberTM) for 6 weeks on fecal SCFA levels, gut microbial composition and immune cell composition in minimal stage II A melanoma patients following surgical treatment.
Conditions
- Melanoma, Stage II
Interventions
- OTHER
-
prebiotic dried chicory root (WholeFiber)
Supplementing with WholeFiber for 6 weeks two times a day (10 g per portion).
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Principal Investigators
-
G. A.P. Hospers, MD, PhD · UMCG
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-26
- Primary Completion
- 2026-03-25
- Completion
- 2027-09-14
Countries
- Netherlands
Study Locations
More Related Trials
-
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
NCT01770431 ·Status: COMPLETED ·Phase: PHASE4
-
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
NCT06368063 ·Status: RECRUITING ·Phase: PHASE4
-
Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
NCT07243691 ·Status: RECRUITING ·Phase: NA
-
Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]
NCT01879878 ·Status: UNKNOWN ·Phase: NA
-
Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC
NCT06900478 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Iscar for Supplemental Care in Stage IV Lung Cancer
NCT00079794 ·Status: COMPLETED ·Phase: PHASE2
-
Isolation and Characterization of Cancer Stem Cells Using iFP Technique
NCT01641003 ·Status: UNKNOWN
-
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
NCT00283478 ·Status: COMPLETED ·Phase: NA
-
Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
NCT06464380 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)
NCT01448668 ·Status: UNKNOWN
-
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
NCT04710290 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)
NCT01448655 ·Status: UNKNOWN
-
Huaier Granule in Treating Women With Triple Negative Breast Cancer
NCT02615457 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Study of MAK Immune Cells in the Treatment of PHC
NCT05242757 ·Status: UNKNOWN ·Phase: NA
-
Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
NCT04246021 ·Status: COMPLETED ·Phase: NA
-
Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer
NCT02948309 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
NCT07337460 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
NCT03984214 ·Status: COMPLETED ·Phase: PHASE3
-
Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma
NCT00149565 ·Status: COMPLETED ·Phase: PHASE3
-
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
NCT00562666 ·Status: TERMINATED ·Phase: PHASE1
-
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer
NCT01964001 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence
NCT07328828 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
NCT01681446 ·Status: UNKNOWN ·Phase: PHASE3
-
Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
NCT06644937 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
NCT00137761 ·Status: COMPLETED ·Phase: PHASE2